| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
From the Pain Relief Unit (Drs. Eisenberg, Lurie, and Braker), the Haifa Pain Research Group (Drs. Eisenberg and Braker), and the Endocrine Institute (Dr. Daoud), Rambam Medical Center, The Technion–Israel Institute of Technology, Haifa; and the Endocrine Institute (Dr. Ishay), Central Emek Hospital, Afula, Israel.
Address correspondence and reprint requests to Dr. E. Eisenberg, Pain Relief Unit, Rambam Medical Center, P.O.B. 9602, Haifa 31096, Israel; e-mail: L_eisenberg{at}rambam.health.gov.il
Objective:— To study the efficacy of lamotrigine in relieving the pain associated with diabetic neuropathy.
Methods:— The authors randomly assigned 59 patients to receive either lamotrigine (titrated from 25 to 400 mg/day) or placebo over a 6-week period. Primary outcome measure was self-recording of pain intensity twice daily with a 0 to 10 numerical pain scale (NPS). Secondary efficacy measures included daily consumption of rescue analgesics, the McGill Pain Questionnaire (MPQ), the Beck Depression Inventory (BDI), the Pain Disability Index (PDI), and global assessment of efficacy and tolerability.
Results:— Twenty-four of 29 patients (83%) receiving lamotrigine and 22 of 30 (73%) patients receiving placebo completed the study. Daily NPS in the lamotrigine-treated group was reduced from 6.4 ± 0.1 to 4.2 ± 0.1 and in the control group from 6.5 ± 0.1 to 5.3 ± 0.1 (p < 0.001 for lamotrigine doses of 200, 300, and 400 mg). The results of the MPQ, PDI, and BDI remained unchanged in both groups. The global assessment of efficacy favored lamotrigine treatment over placebo, and the adverse events profile was similar in both groups.
Conclusions:— Lamotrigine is effective and safe in relieving the pain associated with diabetic neuropathy.
This article has been cited by other articles:
|
|
 |
|
  M. M. Huizinga and A. Peltier Painful Diabetic Neuropathy: A Management-Centered Review Clin. Diabetes, January 1, 2007; 25(1): 6 - 15. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. VADALOUCA, I. SIAFAKA, E. ARGYRA, E. VRACHNOU, and E. MOKA Therapeutic Management of Chronic Neuropathic Pain: An Examination of Pharmacologic Treatment Ann. N.Y. Acad. Sci., November 1, 2006; 1088(1): 164 - 186. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. H. Dworkin, J. Katz, and M. J. Gitlin Placebo response in clinical trials of depression and its implications for research on chronic neuropathic pain Neurology, December 29, 2005; 65(12_suppl_4): S7 - S19. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. M. Rathur and A. J. M. Boulton Recent advances in the diagnosis and management of diabetic neuropathy J Bone Joint Surg Br, December 1, 2005; 87-B(12): 1605 - 1610. [Full Text] [PDF]
|
|
|
|
 |
|
 A. Vinik Use of Antiepileptic Drugs in the Treatment of Chronic Painful Diabetic Neuropathy J. Clin. Endocrinol. Metab., August 1, 2005; 90(8): 4936 - 4945. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. F. Corbett Practical Management of Patients With Painful Diabetic Neuropathy The Diabetes Educator, July 1, 2005; 31(4): 523 - 540. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. A. Irving Contemporary assessment and management of neuropathic pain Neurology, June 28, 2005; 64(12_suppl_3): S21 - S27. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. N. Rubey Treatment of chronic pain in persons with dementia: An overview American Journal of Alzheimer's Disease and Other Dementias, January 1, 2005; 20(1): 12 - 20. [Abstract] [PDF]
|
|
|
|
|
|
A. J.M. Boulton Management of Diabetic Peripheral Neuropathy Clin. Diabetes, January 1, 2005; 23(1): 9 - 15. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Raskin, P. D. Donofrio, N. R. Rosenthal, D. J. Hewitt, D. M. Jordan, J. Xiang, and A. I. Vinik Topiramate vs placebo in painful diabetic neuropathy: Analgesic and metabolic effects Neurology, September 14, 2004; 63(5): 865 - 873. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. J.M. Boulton, R. A. Malik, J. C. Arezzo, and J. M. Sosenko Diabetic Somatic Neuropathies Diabetes Care, June 1, 2004; 27(6): 1458 - 1486. [Full Text] [PDF]
|
|
|
|
|
|
B. D. Nicholson Evaluation and treatment of central pain syndromes Neurology, March 9, 2004; 62(90052): S30 - 36. [Abstract] [Full Text]
|
|
|
|
 |
|
 R. H. Dworkin, M. Backonja, M. C. Rowbotham, R. R. Allen, C. R. Argoff, G. J. Bennett, M. C. Bushnell, J. T. Farrar, B. S. Galer, J. A. Haythornthwaite, et al. Advances in Neuropathic Pain: Diagnosis, Mechanisms, and Treatment Recommendations Arch Neurol, November 1, 2003; 60(11): 1524 - 1534. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. M. Simpson, J. C. McArthur, R. Olney, D. Clifford, Y. So, D. Ross, B. J. Baird, P. Barrett, A. E. Hammer, and the Lamotrigine HIV Neuropathy Study Team Lamotrigine for HIV-associated painful sensory neuropathies: A placebo-controlled trial Neurology, May 13, 2003; 60(9): 1508 - 1514. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R.H. Dworkin, A.E. Corbin, J.P. Young Jr., U. Sharma, L. LaMoreaux, H. Bockbrader, E.A. Garofalo, and R.M. Poole Pregabalin for the treatment of postherpetic neuralgia: A randomized, placebo-controlled trial Neurology, April 22, 2003; 60(8): 1274 - 1283. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
